Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005133 · ClinicalTrials.gov registry record

Cardiovascular Health Study (CHS)

A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Active
Registry status
5,888
Enrollment target
6
Study locations

NCT00005133: Active study of Hypertension and Cardiovascular Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT00005133 is a study of Hypertension and Cardiovascular Diseases that is active but no longer recruiting, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,888 participants, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (68% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005133, a study of Hypertension and Cardiovascular Diseases, is active but no longer recruiting, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

ACTIVE NOT RECRUITING
Registry status
5,888 participants
Enrollment target
6
Study locations

Study Summary

To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.

Study Locations (6)

California

  • University of California, Davis - Sacramento

Maryland

  • Johns Hopkins University - Hagerstown

North Carolina

  • Wake Forest University School of Medicine - Winston-Salem

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Vermont

  • University of Vermont - Colchester

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 5,888 participants
Start Date 1988-06
Est. Completion 2027-12-31

What the registry record for NCT00005133 still lists

NCT00005133 is an observational study that tracks outcomes without assigning an intervention. Its 5,888 participants enrollment target places it among the larger protocols in the corpus, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (68% higher).

The record links to 7 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT00005133 lists 6 locations in 6 states (California, Maryland, North Carolina).

Frequently Asked Questions

What is clinical trial NCT00005133 about?

NCT00005133 is a clinical study titled "Cardiovascular Health Study (CHS)". To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.

What is the current status of trial NCT00005133?

This trial is currently active not recruiting. The enrollment target is 5,888 participants. The study started on 1988-06. Estimated completion is 2027-12-31.

What conditions does trial NCT00005133 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Diabetes Mellitus, Heart Diseases, Heart Failure, Congestive.

Who is sponsoring clinical trial NCT00005133?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005133 being conducted?

This trial has 6 study locations across California, Maryland, North Carolina, Pennsylvania, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00005133's enrollment target sits among peer trials

5,888 26th of 470 higher than 445 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03959085 · 5,951 participants · Phase 3

    Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • NCT06192511 · 5,980 participants · NA

    Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening

  • NCT00005095 · 6,000 participants

    Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

  • NCT00280202 · 6,000 participants

    Detection of Genetic Markers of Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005133, the US trial registry maintained by the National Library of Medicine. NCT00005133 (large enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.